Clinical Trial Update: Phase II Study of LM-24C5 [Phase 2]

View source ↗

Summary

Phase II study of LM-24C5 for advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• LM-24C5

Snippet

Sponsor: LaNova Medicines Limited | Conditions: Advanced Solid Tumor Cancer | Phase 2 | Status: RECRUITING